Tyrian Diagnostics Overview
- Year Founded
-
1999
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$13M
Tyrian Diagnostics General Information
Description
Contango Asset Management Ltd is a wholesale and listed investment company fund manager. The company manages the large-cap, mid-cap, small-cap, micro-cap and income-focused mandates. It also manages three LIC mandates for NAOS Small Cap Opportunities Companies Ltd, Contango Income Generator Ltd and WCM Global Growth Ltd.
Contact Information
Website
www.tyriandx.com
Formerly Known As
Proteome Systems
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Drug Discovery
Acquirer
Primary Office
- Locked Bag 2073
- Post Box 1670
- North Ryde, New South Wales 2113
- Australia
Tyrian Diagnostics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Merger/Acquisition | 24-Jun-2016 | $13M | 000.00 | 0000 | Completed | Generating Revenue |
| 5. PIPE | 25-Aug-2008 | 00.000 | 000.00 | Completed | Generating Revenue | |
| 4. PIPE | 08-Sep-2005 | 00.00 | 000.00 | Completed | Generating Revenue | |
| 3. IPO | 30-Sep-2004 | 0000 | 000.00 | 00000 | Completed | Generating Revenue |
| 2. Grant | 26-Sep-2000 | $1.84M | $9.1M | Completed | Startup | |
| 1. Early Stage VC | 26-Sep-2000 | $9.1M | $9.1M | 000.00 | Completed | Startup |
Tyrian Diagnostics Patents
Tyrian Diagnostics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2011901686-A0 | Method of diagnosis of infection by mycobacteria and reagents therefor | Inactive | 06-May-2011 | ||
| AU-2011901708-A0 | Methods of diagnosis and treatment of m. tuberculosis infection and reagents therefor vii | Inactive | 06-May-2011 | ||
| AU-2011901709-A0 | Methods of diagnosis and treatment of m. tuberculosis infection and reagents therefor viii | Inactive | 06-May-2011 | ||
| AU-2011901684-A0 | Method of diagnosis of infection by mycobacteria and reagents therefor | Inactive | 06-May-2011 | ||
| AU-2011901691-A0 | Method of diagnosis of infection by mycobacteria and reagents therefor | Inactive | 06-May-2011 |
Tyrian Diagnostics Former Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| BTC Health | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Challenger International (Australia) | Corporation | Minority | 000 0000 | 000000 0 | |
| Government of Australia | Government | 000 0000 | 000000 0 | ||
| OppenheimerFunds | Asset Manager | Minority | 000 0000 | 000000 0 | |
| QIC | Sovereign Wealth Fund | Minority | 000 0000 | 000000 0 |
Tyrian Diagnostics Investments (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Charles River Proteomic Services | 02-Oct-2002 | 00000 0000 | 000 | Laboratory Services (Healthcare) | 00000 000 |
Tyrian Diagnostics Exits (1)
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Charles River Proteomic Services | 02-Oct-2002 | 00000 0000000 | 000 | Completed |
|